Announcements Trials
Browse Landscape

Status

Completed 4Recruiting 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 2Gastrointestinal 2Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Pain 1Neoplasms, Plasma Cell 1Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Dexamethasone 48Calcium Dobesilate 20Bortezomib 20Lenalidomide 19Melphalan 16daratumumab 11Cyclophosphamide 11pomalidomide 10elotuzumab 8carfilzomib 8dexamethasone acetate 7pembrolizumab 6ixazomib 6fludarabine phosphate 6dexamethasone 21-phosphate 6venetoclax 5selinexor 5fludarabine 5auricularum 5Filgrastim 5liposomal doxorubicin 4Thalidomide 4Tacrolimus 4Peripheral Blood Stem Cell Transplantation 4Magnetic Resonance Spectroscopy 4Whole-Body Irradiation 3Vorinostat 3Simvastatin 3Nivolumab 3Mycophenolic Acid 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Interviews as Topic × Plasma cell × Clear all
NCT01016028 2016-05-03

Chemotherapy-Induced Peripheral Neuropathy Survey

M.D. Anderson Cancer Center

Withdrawn
BreastGastrointestinalPlasma cell

Breast Neoplasms, Neoplasms, Pain, Colorectal Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡